To understand how a disease progresses or how a drug functions, biomedical research historically relies on a classic reductionist strategy: isolate the variables. By extracting a specific cell type and growing it in a controlled plastic dish (in vitro), researchers can eliminate the chaotic background noise of a living organism to map precise molecular pathways.
Through this approach, we can pinpoint how specific compounds alter cellular machinery—such as how baicalin suppresses the Wnt/β-catenin pathway in cardiomyocytes (Liman Qiu et al.) or how human cervical cells deploy the TLR4-MyD88 axis to flag viral infections (Hongya Liu et al.)).
Yet, this isolation introduces a fundamental problem: the physiological complexity gap. A living organism is not merely a collection of independent cells; it is an integrated system defined by fluid dynamics, multi-organ feedback loops, and structural microenvironments. When we remove cells from this context, the pathways we observe in isolation often fail to predict clinical reality. As early work by William L. Henrich et al. demonstrated, using simplified or non-functional organ models to isolate variables frequently yields results that do not reflect how mechanisms interact within a living, intact system.
The Missing Dimensions of Systemic Complexity
Why exactly do robust in vitro findings fail to translate in vivo? The breakdown typically occurs across three missing dimensions of systemic complexity.
1. Hemodynamic and Mechanical Forces
Cells in a static culture dish experience a completely different physical environment than cells in a living body. Vascular and cardiac tissues, for instance, are constantly shaped by blood flow, hydrostatic pressure, and mechanical shear stress.
When researchers evaluate protective agents against endothelial injury (Liangqing Zhang et al.; Sijie Wang et al.) or model podocyte survival in the kidney (Jing Liu et al.), they are looking at cells stripped of these physical cues. Michiaki Hamada et al. illustrated this gap by showing that mechanical pressure independently triggers smooth muscle cells to synthesize glycosaminoglycans. Without simulating these physical forces, an in vitro model cannot accurately replicate the integrated biological response of a complete arterial wall or beating heart.
2. Multi-Organ Cross-Talk and ADME Dynamics
An isolated cell culture operates in a metabolic vacuum. In a whole organism, any administered substance undergoes Absorption, Distribution, Metabolism, and Excretion (ADME)—processes managed by the gut, liver, and kidneys.
Paweł Jarosiewicz et al. highlighted this limitation when evaluating chemical toxicities, noting that isolated cell lines cannot replicate how a whole organism metabolizes or excretes compounds. Similarly, studying how prebiotics modulate the gut microbiota using a closed fermentation flask misses the dynamic intestinal absorption and immune system feedback loops that characterize the living gut-brain axis (Liemin Ruan et al.).
3. Cellular Heterogeneity and Microenvironments
Diseases are rarely monocultures. Complex conditions like sepsis involve an intricate cascade between endothelial cells, neutrophils, and tissue-resident immune cells. As Ling Wu notes, evaluating these processes in a single monocytic cell line fails to capture the systemic orchestration of a real immune response.
In the brain, modeling neuroinflammation requires accounting for the bidirectional communication between astrocytes and microglia, alongside a functional blood-brain barrier (Heejung Chun et al.). When researchers isolate spinal cord slices, they lose the systemic feedback loops, blood flow, and descending inhibitory signals from the brain that govern pain sensitization (Jaekwang Lee et al.). Even standard blood tests often isolate plasma, neglecting the critical interactions between clotting factors and active cellular components like platelets (Shichun Wang et al.).
The Disappearance of Emergent Properties
The core reason the physiological complexity gap matters is the concept of emergent properties—behaviors of a system that cannot be predicted by studying its parts in isolation.
For example, an engineered cell line might be highly effective for screening an isolated ion channel target, but it cannot simulate the emergent electrical properties of an integrated neural or cardiac circuit (Gabriel B. Borja et al.). Similarly, while simple invertebrate models are valuable for genetic screening, they lack the sophisticated vascular and neural architectures required to accurately mimic human organ diseases (Priyanka Joshi et al.).
When exploring systemic pathologies such as preeclampsia (Huafang Wei et al.) or chronic kidney disease (Adalbert Raimann et al.; Jun Zhang et al.), the molecular pathways identified in a dish must eventually be validated in a living model. Without the whole-body inflammatory response and circulating immune cells, even ex vivo whole-organ models can fail to capture true physiological outcomes, as argued by the authors of a study on myocardial ischemia (Apelin receptor inhibition in ischemia-reperfused mouse hearts protected by endogenous n-3 polyunsaturated fatty acids).
[Isolated Monoculture] ──> Misses: Shear Stress, ADME, Cellular Cross-talk
│
▼
[Physiological Gap] ──> Results in: Loss of Emergent Circuit/Organ Properties
│
▼
[Translational Failure] ──> Clinical trials fail despite robust in vitro data
Bridging the Gap with New Approach Methodologies
To resolve this tension between experimental control and biological reality, researchers are developing New Approach Methodologies (NAMs) designed to reintroduce systemic complexity in a controlled manner.
- Digital and High-Parallelism Organ-on-a-Chip Systems: Early microfluidic models of organs like the liver were often oversimplified representations. To address this, Guohua Wu et al. developed array-based "digital" organ-on-a-chip platforms that use uniform cellular microspheres to better replicate the structural complexity and microenvironments of human tissues.
- Vascularized and Immune-Integrated Organoids: Traditional 3D neural organoids lack blood vessels and immune components like microglia. To improve toxicological risk assessments, frameworks proposed by TinChung Leung et al. advocate for multi-tiered testing that combines human cell lines, vascularized 3D organoids, and complete alternative models (like zebrafish) to capture systemic neurotoxicity.
By transitioning from static, isolated monocultures to dynamic, multicellular, and fluidic environments, modern biomedical research aims to close the physiological complexity gap—ensuring that the molecular mechanisms we discover in the laboratory are the same ones operating inside the human body.
Key Foundational Work
Mechanisms of Renin Secretion during Hemorrhage in the Dog (1979) — contributed 1 concept elements to this direction.
Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity. (1983) — contributed 1 concept elements to this direction.